Gregory Licholai
Chief Tech/Sci/R&D Officer en ICON PUBLIC LIMITED COMPANY .
Perfil
Fundador de Immunome, Inc., Gregory P. Licholai es actualmente Director Médico y de Innovación de ICON plc y Presidente de Elpidera LLC. El Dr. Licholai también forma parte del consejo de administración de Sollis Therapeutics, Inc. Anteriormente ocupó el cargo de Presidente y Director Científico de Castle Creek Pharmaceuticals LLC, Vicepresidente de Asuntos Médicos de Amicus Therapeutics, Inc. y Director de Empresas y Asociados de Medtronic Neurological y Director de Immunome, Inc. Gregory P. Licholai se licenció en el Boston College, se doctoró en la Universidad de Yale y obtuvo un MBA en la Universidad de Harvard.
Cargos activos de Gregory Licholai
| Empresas | Cargo | Inicio |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| Elpidera LLC | President | - |
Antiguos cargos conocidos de Gregory Licholai.
| Empresas | Cargo | Fin |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | President | 01/02/2018 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/10/2009 |
| Medtronic Neurological | Corporate Officer/Principal | 01/11/2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formación de Gregory Licholai.
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Yale School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Medtronic Neurological | |
| Elpidera LLC | |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory Licholai
